A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects

Contraception

Volumn 37, Issue 1, 1988, Pages 1-20

  Said, S ^a   Sadek, W ^a   Knoieif, A ^a   Koetsawang, Suporn ^b   Kiriwat, Orawan ^b   Piboonmanee, Surat ^b   Rivera, R ^c   Alvarado, G ^c   Juarez, M A ^c   Aguliar, S ^c   Santiso, R ^d   Contreras, C F ^d   Galichi, L F ^d   Guliora, M ^d   Alzugaray, M G ^e   Hernandez, M L ^e   Gallardo, J R ^e   Affandi, B ^f   Santoso, S S I ^f   Jamil, R S ^f   Kazi, A ^g   Kononova, E S ^h   Ailpov, V I ^h   Apeio, R ⁱ   Hernardo, E S ⁱ   Benitez, I ⁱ   more..

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Inst de Investigacion Cientifica   (Mexico)

^d Asociacion Pro Bienestar de la Famiiia de Guatemala ^*  (Guatemala)

^e INSTITUTO NACIONAL DE ENDOCRINOLOGÍA   (Cuba)

^f UNIVERSITY OF INDONESIA   (Indonesia)

^g Natl Res Inst for Fertil Control   (Pakistan)

^h D O OTT RESEARCH INSTITUTE OF OBSTETRICS   (Russian Federation)

ⁱ Dr Jose Fabella Memorial Hospital   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPROVERA; ESTRADIOL CIPIONATE; ESTRADIOL VALERATE; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE;

AMENORRHEA; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AMENORRHEA; BLOOD PRESSURE; BODY WEIGHT; CLINICAL TRIALS; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; ESTRADIOL; FEMALE; HUMAN; MEDROXYPROGESTERONE; PATIENT COMPLIANCE; PREGNANCY; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T;

EID: 0023853155     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(88)90144-8     Document Type: Article

References (14)

1. Long-acting injectable formulations
2. Patterns of bleeding associated with the use of steroidal contraceptives
3. Long-acting systemic contraceptives
4. The clinical use of monthly injectable contraceptive preparations
5. Monthly injectable contraceptives
6. A comparison of the pharmacokinetic profiles of three estradiol esters
7. Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations
8. A multicentred pharmacokinetic pharmacodynamic study of once-a-month injectable contraceptives: I. Different doses of HRP112 and of Depoprovera
9. A multicentred pharmacokinetic pharmacodynamic study of once-a-month injectable contraceptives: II. Different doses of HRP102 and of norethisterone enantate
10. A multinational comparative clinical trial of long-acting injectable contraceptives: Norethisterone enantate given in two dosage regimens and depot-medroxyprogesterone acetate, Final Report
11. Sample size requirements for evaluating a conservative therapy
12. Life-table methods for contraceptive research
13. A multicentred Phase III comparative clinical trial of depot-medroxyprogesterone acetate given three monthly at doses of 100 mg or 150 mg: I. Contraceptive efficacy and side effects
14. A multicentred Phase III comparative clinical trial of depot-medroxyprogesterone acetate given three monthly at doses of 100 mg or 150 mg: II. Comparison of bleeding patterns